NCT02072278View on ClinicalTrials.gov

Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

November 30, 2014

Conditions
Healthy Men
Interventions
DRUG

Vortioxetine 10 mg

DRUG

Vortioxetine 20 mg

DRUG

Escitalopram 15 mg

DRUG

Placebo

Trial Locations (1)

35000

FR801, Rennes

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT02072278 - Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects | Biotech Hunter | Biotech Hunter